Hormone replacement therapy remains the most effective treatment for the relief of menopausal symptoms and is an essential part of the management of women with premature ovarian failure. Over recent months, media coverage of HRT has left women anxious over its safety, and some prescribers may be unclear of the current evidence. This article summarises the current evidence so prescribers may be confident in offering this treatment for menopause, based on individualized risk.
No takes yet. Share an insight, caveat, or question.
Kathy Abernethy (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: